SCHEMBL2596698

SCHEMBL2596698

CC(C)c1cc2c(-n3c(O)nnc3-c3cc(C(C)C)c(O)cc3O)cccc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 20/20 0.41
HSP90AB1 P08238 19/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2596689 0.77 DAO (0.34) HSP90AA1HSP90AB1
SCHEMBL13280018 0.77 DAO (0.34) HSP90AA1HSP90AB1
SCHEMBL420145 0.77 HSP90AA1 (0.43) HSP90AA1HSP90AB1
SCHEMBL1539292 0.73 HSP90AA1 (0.36) HSP90AA1HSP90AB1
SCHEMBL1586062 0.70 HSP90AA1 (0.38) HSP90AA1HSP90AB1
SCHEMBL789420 0.70 HSP90AA1 (0.49) HSP90AA1HSP90AB1
SCHEMBL4743521 0.69 HSP90AA1 (0.57) HSP90AA1HSP90AB1
SCHEMBL18649798 0.68 HSP90AA1 (0.49) HSP90AA1HSP90AB1
SCHEMBL12047156 0.67 HSP90AA1 (0.68) HSP90AA1HSP90AB1
SCHEMBL20879033 0.67 HSP90AA1 (0.49) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011146801-A1 FORMULATION AND DOSING OF HSP90 INHIBITORY COMPOUNDS SYNTA PHARMACEUTICALS CORP. (US) 2011-11-24 WO claimed
EP-2678014-A2 PROSTATE CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS Synta Pharmaceuticals Corp. (US) 2014-01-01 EP disclosed
WO-2012141796-A2 PROSTATE CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS SYNTA PHARMACEUTICALS CORP. (US) 2012-10-18 WO disclosed